< Back To Initiatives

Clinical Research Awareness & Access

Rationale

The Clinical Research Awareness & Access Initiative targets TransCelerate’s strategic priority of improving the patient experience by enabling a better informed patient.

Clinical trial participation is often not considered as an option for medical care and can be difficult to pursue given a lack of relevant and actionable information on clinical trial opportunities. Meanwhile, the role and expectations of patients and health consumers continue to evolve as they take more ownership of their own health care and health data.

Clinical Research Awareness & Access seeks to facilitate and support sponsors’ efforts to make clinical trial information, data and participation more transparent, more accessible, and more patient-friendly. The aim is to give patients the tools and options they need to make informed choices about volunteering and/or continuing participation in clinical research, based on a robust understanding of the benefits and risks to them and to the healthcare system more broadly.

Benefits

We ultimately expect to help achieve:

  • Increased awareness of, and public engagement with, clinical research
  • Improved availability of meaningful information on clinical trial opportunities
  • More informed and empowered study participants

Available Assets

The following assets will be delivered by this initiative:

  • Key messages, content, and structured approach for a clinical trial awareness campaign
  • A position paper on transparency of relevant site contact information
  • Potential options for effectively sharing meaningful data, results, and study information with patients (considering the full trial life cycle – before, during and after)
  • An exploration of mechanisms and tools available (or create where lacking) to help increase accessibility and functionality for patients during trial search

Please check back for more information.

Similar Initiatives

eLabels

The TransCelerate eLabels initiative will help the industry progress on the journey to digitally supported, patient-centric clinical supply chains.

LEARN MORE >

eConsent

The eConsent Initiative will create a common approach for the electronic consenting of patients using an array of digital elements and process efficiencies to increase insight patients’ understanding, increase regulatory compliance, and reduce quality risks.

LEARN MORE >

Placebo and Standard of Care Data Sharing

The Placebo and Standard of Care (PSoC) Initiative was established to enable the sharing of data to maximize the value of clinical data collected historically in the placebo and standard of care control arms of clinical trials.

LEARN MORE >
Translate »